Hims & Hers Health Inc

• CVS Health launched new GLP-1 weight management services and virtual consultation programs. • Financial analysts raised price targets following the company's strategic expansion into GLP-1 markets. • CVS reported improved quarterly earnings and updated guidance amid ongoing operational restructuring efforts.

• CVS Health price increased due to analyst upgrades and strong earnings. • Q1 2026 earnings surpassed expectations, with raised full-year guidance. • Stock shows mixed signals from valuation and insider selling.

• HCA Healthcare Q1 2026 results missed adjusted EBITDA expectations. • Company reaffirmed 2026 guidance, disappointing some investors. • Lower patient admissions and surgeries impacted operational performance.

• Analyst price target reductions pressured Intuitive Surgical stock. • FDA alerts and recalls on stapling devices created regulatory concerns. • Company guidance projected slower procedure growth and tariff impacts.

• Abbott's Q1 earnings and revenue exceeded expectations. • Full-year earnings guidance was lowered due to Exact Sciences acquisition. • Regulatory scrutiny and Nutrition segment decline pressured stock.

• UnitedHealth Group Q1 2026 revenue exceeded expectations at $111.7 billion. • Medical care ratio improved to 83.9%, and full-year EPS outlook raised. • CMS 2027 Medicare Advantage rate increase provides significant tailwind.